Results 261 to 270 of about 2,118,089 (307)

The epidemiology of respiratory tract infections

Seminars in Respiratory Infections, 2000
Respiratory tract infections (RTIs) are the most common, and potentially most severe, of infections treated by health care practitioners. Lower RTIs along with influenza, are the most common cause of death by infection in the United States. Risk factors for pneumonia and other respiratory tract infections include: extremes of age (very young and ...
openaire   +2 more sources

Lower Respiratory Tract Infections

Infectious Disease Clinics of North America, 2004
Lower respiratory tract infections (LRTIs) are among the most common infections treated by health care providers. They include a variety of infections ranging from mild acute viral bronchitis to life-threatening ventilatorassociated pneumonia. Despite advances in general knowledge concerning such diseases, there remains considerable morbidity and ...
openaire   +2 more sources

Neonatal respiratory tract infections

International Journal of Antimicrobial Agents, 1993
Neonatal respiratory tract infections, in particular pneumonia, can be life-threatening. Lower respiratory tract infections may be acquired before, during, or after birth. Upper respiratory tract infections include otitis, sinusitis, rhinitis, laryngitis, tracheitis and bronchitis.
openaire   +2 more sources

Telithromycin in Lower Respiratory Tract Infections

Future Microbiology, 2006
Telithromycin is a ketolide, a semisynthetic derivative of the 14-membered ring macrolide antibiotics, with an expanded spectrum of activity relative to macrolides. Its good tissue pharmacokinetic characteristics allows once-daily administration, and it has been successfully employed in lower respiratory tract infections.
F. Blasi, M. Cazzola, P. Tarsia, S. Aliberti, C. Baldessari, V. Valenti   +5 more
openaire   +2 more sources

Streptococcus pneumoniae respiratory tract infections

Current Opinion in Infectious Diseases, 2001
This review describes recent contributions to our understanding of pneumococcal pneumonia. Two genes have been described that encode enzymes involved with the biosynthesis of muropeptides. These enzymes may be novel antibiotic targets. The clinical impact of increasing antibiotic resistance on the treatment of pneumonia is the particular focus of the ...
K P, Klugman, C, Feldman
openaire   +2 more sources

Lower Respiratory Tract Infections

Primary Care: Clinics in Office Practice, 1990
Although lower respiratory tract infections are frequently diagnosed in a primary care setting, they are still associated with a significant morbidity and mortality, which warrants a careful approach to treatment. Knowledge of the most common cause based on the age of the patient, location where the infection was acquired, and clinical presentation ...
openaire   +2 more sources

Upper Respiratory Tract Infections

Primary Care: Clinics in Office Practice, 1990
Upper respiratory tract infections are among the most common acute infections in humans. This review discusses the clinically important aspects of the epidemiology, etiology, clinical presentation, diagnosis, management, complications, and prevention of the common cold, pharyngitis, otitis media, and sinusitis.
openaire   +2 more sources

Erythromycin in Respiratory Tract Infection

Scottish Medical Journal, 1977
One of the main uses of erythromycin in respiratory tract infection has been in the treatment of acute streptococcal tonsillitis as an alternative to penicillin. Studies on the quantitative bacteriology of tonsils obtained at tonsillectomy have shown large numbers of both haemolytic streptococci and Haemophilus species in most samples
openaire   +2 more sources

Moxifloxacin in respiratory tract infections

Expert Opinion on Pharmacotherapy, 2005
Moxifloxacin is a fourth-generation fluoroquinolone that has been shown to be effective against respiratory pathogens, including Gram-positive (Streptococcus pneumoniae), Gram-negative (Haemophilus influenzae, Moraxella catarrhalis), and atypical strains (Chlamydia pneumoniae, Mycoplasma pneumoniae), as well as multi-drug resistant S.
openaire   +2 more sources

Infections of the Respiratory Tract

1988
Acute respiratory infections (ARI) are a leading cause of death in developing countries. Figures published by UNICEF indicate that 97% of deaths of children less than 1 year old, and 98% of deaths of children aged 1–5 years occur in third world countries, where 75% of the world’s population live.
Sabine Enenkel, Wolfgang Stille
openaire   +1 more source